MAPT and Alzheimer disease: Alzheimer’s disease (AD) is a neurodegenerative disorder characterized by abnormal tau protein metabolism, the presence of the insoluble extracellular amyloid-β peptide (Aβ) aggregates, an inflammatory response, and cholinergic and free radical damage.